TrianglePUBLICATIONS · 9671874
Liarozole--a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate. Liarozole Study Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Urology
- Publication date
- 1998 Jul
- First author
- Debruyne FJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Debruyne FJ
- type
- Author
- name
- Murray R
- type
- Author
- name
- Fradet Y
- type
- Author
- name
- Johansson JE
- type
- Author
- name
- Tyrrell C
- type
- Author
- name
- Boccardo F
- type
- Author
- name
- Denis L
- type
- Author
- name
- Marberger JM
- type
- Author
- name
- Brune D
- type
- Author
- name
- Rassweiler J
- type
- Author
- name
- Vangeneugden T
- type
- Author
- name
- Bruynseels J
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Debruyne FJ
- type
- Author
- name
- Murray R
- type
- Author
- name
- Fradet Y
- type
- Author
- name
- Johansson JE
- type
- Author
- name
- Tyrrell C
- type
- Author
- name
- Boccardo F
- type
- Author
- name
- Denis L
- type
- Author
- name
- Marberger JM
- type
- Author
- name
- Brune D
- type
- Author
- name
- Rassweiler J
- type
- Author
- name
- Vangeneugden T
- type
- Author
- name
- Bruynseels J
- type
- Author
- bibliography ids
- nci-bib-8a059bf9dbb4a5d01db3c6dc
- book metadata
- content sha256
- e9bf2a395a312c457bf5ce481a341d1629e4967e2bb6d008f653ae3d1bb0ff7a
- document type
- citation
- dois
- 10.1016/s0090-4295(98)00129-0
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:9671874
- immutable id
- pubmed:9671874@e9bf2a395a312c457bf5ce481a341d1629e4967e2bb6d008f653ae3d1bb0ff7a
- journal
- abbreviation
- Urology
- issn electronic
- Source null
- issn print
- 0090-4295
- issue
- 1
- name
- Urology
- nlm unique id
- 0366151
- pages
- 72-81
- volume
- 52
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 9671874
- provenance
- batch id
- 7e001e36165c25a91a06
- provider
- NCBI PubMed ESummary
- record sha256
- 287f7bc70858333667295a98b34edd5dbbfe65eb3961d0043ddafc7561d5745b
- response sha256
- 3515b9c50c264ae766881ea5a6c5cb10e3af8e45341fd57a5bedfa1946d08222
- retrieved at
- 2026-09-09T23:45:31.509029+00:00
- publication date
- display
- 1998 Jul
- precision
- month
- year
- 1998
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/9671874/
- title
- Liarozole--a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate. Liarozole Study Group.
Preserved source evidence · Not medical advice